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ABSTRACT The emergence of azole resistance in the pathogenic fungus Aspergillus
fumigatus has continued to increase, with the dominant resistance mechanisms, con-
sisting of a 34-nucleotide tandem repeat (TR34)/L98H and TR46/Y121F/T289A, now
showing a structured global distribution. Using hierarchical clustering and multivari-
ate analysis of 4,049 A. fumigatus isolates collected worldwide and genotyped at
nine microsatellite loci using analysis of short tandem repeats of A. fumigatus
(STRAf), we show that A. fumigatus can be subdivided into two broad clades and
that cyp51A alleles TR34/L98H and TR46/Y121F/T289A are unevenly distributed across
these two populations. Diversity indices show that azole-resistant isolates are geneti-
cally depauperate compared to their wild-type counterparts, compatible with selec-
tive sweeps accompanying the selection of beneﬁcial mutations. Strikingly, we found
that azole-resistant clones with identical microsatellite proﬁles were globally distrib-
uted and sourced from both clinical and environmental locations, conﬁrming that
azole resistance is an international public health concern. Our work provides a
framework for the analysis of A. fumigatus isolates based on their microsatellite pro-
ﬁle, which we have incorporated into a freely available, user-friendly R Shiny applica-
tion (AfumID) that provides clinicians and researchers with a method for the fast, au-
tomated characterization of A. fumigatus genetic relatedness. Our study highlights
the effect that azole drug resistance is having on the genetic diversity of A. fumiga-
tus and emphasizes its global importance upon this medically important pathogenic
fungus.
IMPORTANCE Azole drug resistance in the human-pathogenic fungus Aspergillus fu-
migatus continues to emerge, potentially leading to untreatable aspergillosis in im-
munosuppressed hosts. Two dominant, environmentally associated resistance mech-
anisms, which are thought to have evolved through selection by the agricultural
application of azole fungicides, are now distributed globally. Understanding the ef-
fect that azole resistance is having on the genetic diversity and global population of
A. fumigatus will help mitigate drug-resistant aspergillosis and maintain the azole
class of fungicides for future use in both medicine and crop protection.
KEYWORDS Aspergillus fumigatus, antifungal chemicals, azole resistance, fungal
pathogen, fungicides, global distribution
Aspergillus fumigatus is a ubiquitous, globally distributed ascomycete fungus with anecological niche of decaying vegetation and soil (1). In recent years, questions
regarding the ecology and evolution of A. fumigatus, motivated primarily by the
organism’s ability to infect immunocompromised hosts but also by the emergence of
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antifungal drug resistance, have been raised (2–4). A. fumigatus is an opportunistic
pathogen causing a spectrum of respiratory illnesses, from asthma-like symptoms to
invasive aspergillosis (IA), where mortality rates of 40 to 90% have been reported in
immunocompromised patients (5–7). There is a limited arsenal of drugs available for
the treatment and prophylaxis of A. fumigatus-related aspergillosis, with the azole
antifungals itraconazole, posaconazole, and voriconazole acting as the frontline de-
fense against this disease (8).
Predictably, resistance to azole antifungals has emerged, and in recent years there
have been increasing reports of resistant A. fumigatus isolates recovered from patients
with aspergillosis (9). Resistance to azole antifungals can evolve during azole therapy
(10–12); however, the extensive use of agricultural azole compounds in the environ-
ment for crop protection has now been linked to the emergence of azole resistance in
A. fumigatus populations (4, 13–16). The most commonly occurring mechanisms of
azole resistance are alterations in cyp51A (erg11), the gene encoding sterol 14-
demethylase (cytochrome P450 51A [CYP51A]), which is the target protein of azole
antifungals (17–19). In A. fumigatus, resistance is most frequently caused by a tandem
repeat (TR) in the promoter that is linked to single nucleotide polymorphisms (SNPs) in
the coding sequence, exempliﬁed by the widespread occurrence of two alleles, TR34/
L98H and TR46/Y121F/T289A (9, 20). The most frequently observed genotype, TR34/
L98H, consists of a 34-nucleotide tandem repeat (TR34) in the cyp51A promoter that
upregulates mRNA expression and a leucine-to-histidine substitution in the coding
sequence that most likely affects the interaction between the azole ligand and the
protein heme cofactor (21–23). The less frequent but emerging genotype, TR46/Y121F/
T289A, is also known to have elevated mRNA expression, and it has been shown that
TR46 in association with two SNPs (Y121F/T289A) confers high levels of resistance to
azoles, including voriconazole (24).
Delineating the genetic diversity and evolutionary life history of pathogenic fungi
can help elucidate the epidemiology of infection, aid in the prophylaxis and treatment
of the disease-causing pathogen, and further our understanding of antifungal resis-
tance evolution (25). Multiple studies conducted in the past 30 years have used a range
of molecular markers to help unravel the population genetics of A. fumigatus (14,
26–31). Findings have ranged from no genetic structure to multiple distinct clusters,
with varying reproducibility being found across methodologies. One commonly recur-
ring feature nonetheless has been the identiﬁcation of two well-supported phyloge-
netic clades (9, 29, 32–35). Preliminary studies utilizing high-resolution whole-genome
sequencing found that isolates harboring TR34/L98H were not randomly distributed
across the phylogeny and that the two-clade population structure could be the result
of azole-resistant genotypes perturbing the natural population structure of A. fumigatus
via selective sweeps (9, 32).
Despite this, little is still known about the global distribution of azole resistance
across the wider A. fumigatus metapopulation and the genetic relationships between
azole-resistant isolates recovered from the environment and patients (36). Here, we
amend these gaps in our knowledge by analyzing the genetic relatedness of a
collection of 4,049 A. fumigatus isolates sampled worldwide and genotyped at 9
microsatellite loci within the context of the resistance genotypes TR34/L98H and
TR46/Y121F/T289A. The methodology used in this study forms the basis of a user-
friendly bioinformatic tool, AfumID, for clinicians and researchers to genetically char-
acterize novel A. fumigatus isolates within the context of the wider population genetic
structure of this fungus.
RESULTS
Genetic clustering of A. fumigatus. Of the 4,049 A. fumigatus isolates, a total of 385
alleles were recorded across the nine microsatellite loci analyzed. All loci were poly-
morphic, with the number of alleles per locus ranging from 25 to 101. Average Nei’s
gene diversity for all loci was 0.87, varying between 0.76 and 0.97 for individual loci.
There were 2,293 represented multilocus genotypes (MLGs).
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Analysis of Bruvo’s distances, to investigate the genetic relationship between iso-
lates, showed no signiﬁcant bootstrap support for any major nodes (70%) but some
support for nodes connecting a small number of isolates (see Fig. S4 in the supple-
mental material). A predominantly distinct subset of isolates did form a small, well-
supported clade, and these isolates appeared to be fundamentally different from the
majority of the other isolates.
Hierarchical clustering of Bruvo’s distances by Ward’s method identiﬁed two broadly
divergent clades, with 1,003 isolates being assigned to clade A and 1,781 being
assigned to clade B (Fig. 1a). Principal-coordinate analysis (PCoA) on Bruvo’s distances
further conﬁrmed the existence of these two clusters when visualized, with moderate
overlap on the ﬁrst two PCoA axes, which accounted for the majority of the genetic
diversity in the data (46.78% and 34.24% of the total variance, respectively), being seen
(Fig. 1b). A 2-dimensional kernel density overlaid on the PCoA scatter plot, used to
highlight compactness within the two clusters, suggested the existence of additional,
more loosely deﬁned subclusters within clades A and B (Fig. S5). Discriminant analysis
of principal components (DAPC) cross validation further conﬁrmed that the two clades
were indeed genetically distinct, with the rate of success in assigning isolates to their
correct clade using only their allelic proﬁles being 97%, a rate far exceeding random
expectations (Fig. 1c; Fig. S6). Allele richness, which here indicates variations in genetic
FIG 1 Genetic clustering and population differentiation of 4,049 Aspergillus fumigatus isolates genotyped at nine microsatellite loci. (a) Dendrogram
representing the hierarchical clustering of isolates by Ward’s method. The relationship between isolates was determined using Bruvo’s distance. The red line
indicates how the tree was divided for population deﬁnition. (b) Principal-coordinate analysis of Bruvo’s genetic distances between 4,049 A. fumigatus isolates
factorially partitioned using populations based on prior hierarchical clustering. (c) Individual density plot from a modiﬁed discriminant analysis of principal
components (DAPC) representing the ﬁrst discriminant function. Populations A and B were discriminated by prior hierarchical clustering. (d) Bar plots illustrating
the division of CYP51A alleles (WT, TR34/L98H, TR46/Y121F/T289A) across the two predicted populations. Thin black bars represent frequency changes after clone
correction.
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diversity, differed between the two clades, with group A having 268 alleles and group
B having 345 alleles.
The frequency of the TR34/L98 and TR46/Y121F/T289A resistance genotypes was not
evenly distributed across the two clades both with and without a clone correction step
(Pearson’s chi-square test, 2 205.39, degrees of freedom [df] 2, and P 2.2e16
and 2 152.67, df 2, and P 2.2e16, respectively; Fig. S7). Clade A, which had 639
isolates with an annotated CYP51A allele, consisted of 44.4% TR34/L98H, 19.4% TR46/
Y121F/T289A, and 36.2% wild-type (WT) isolates. Clade B, which had 473 isolates with
an annotated CYP51A allele, consisted of 12.1% TR34/L98H, 13.7% TR46/Y121F/T289A,
and 74.2% WT isolates (Fig. 1d).
Genetic diversity of azole-resistant A. fumigatus isolates. Allelic richness (the
total number of MLGs) was lower in the TR34/L98H (n 175) and TR46/Y121F/T289A
(n 74) groups than in the WT group (n 439). As richness is inﬂuenced by sample
size, the number of effective multilocus genotypes (eMLGs) was also analyzed; both
resistant groups—TR34/L98H (n 110) and TR46/Y121F/T289A (n 74)—retained a
lower number of eMLGs than the WT group (n 164), despite rarefaction to the
smallest sample size.
According to all three diversity indices (Fig. 2a to c), the Shannon-Wiener diversity
index (H; df 2, P 0.001), Simpson’s index (; df 2, P 0.001), and the standardized
Stoddart and Taylor’s index (G=; df 2, P 0.001), the resistant populations were
signiﬁcantly less diverse than the WT population (Fig. 2a to c). This held true with the
introduction of a clone correction step, although, as expected, the diversity of popu-
lations with the TR34/L98H and TR46/Y121F/T289A genotypes did increase due to the
reduction in the frequency of clonal genotypes (Fig. S8). There was a signiﬁcant
difference between the TR34/L98H and TR46/Y121F/T289A genotypes for H (df 2,
P 0.001) but no signiﬁcant difference for  (df 2, P 0.268) and G= (df 2,
FIG 2 Genetic diversity indices of resistant Aspergillus fumigatus isolates harboring either the WT, TR34/L98H, or TR46/Y121F/T289A CYP51A allele. (a)
Shannon-Wiener index of MLG diversity (H) (61); (b) the standardized Stoddart and Taylor’s index of MLG diversity (G=) (63); (c) Simpson’s index of MLG diversity
() (60); (d) index of association (rd), which represents the clonal relationship of isolates (65, 66). Conﬁdence intervals were generated with 1,000 bootstrap
samples using the R package poppr. Pop, population.
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P 0.948). Isolates with the TR34/L98H and TR46/Y121F/T289A genotypes had a higher
standardized index of association than the wild-type isolates, demonstrating a relation-
ship among azole-resistant isolates more clonal than that found among wild-type
isolates (df 2, P 0.001) (Fig. 2d).
Distribution of azole-resistant multilocus genotypes. There was no signiﬁcant
correlation between pairwise genetic and geographic distances for the TR34/L98H
(r2 0.0299; P 0.444), TR46/Y121F/T289A (r2 0.0476, P 0.434), or WT (r2
0.0762, P 0.729) genotype (Fig. S9). Therefore, there were no spatially structured
patterns of genetic variation (isolation by distance [IBD]) for either the resistant or the
WT isolates. Resistant MLGs were globally distributed, spanning multiple countries and
multiple continents (Fig. 3). For example, isolates harboring TR34/L98H with identical
microsatellite proﬁles (MLGs) were collected in Tanzania (Africa), Romania (Europe), and
India (Asia). Additionally, TR46/Y121F/T289A-containing isolates were also widely dis-
tributed, with one MLG being found in four European countries (France, Germany,
Ireland, and The Netherlands) and another closely related MLG being found in both
Germany (Europe) and Colombia (South America). Resistant isolates with matching
MLGs were also distributed among clinical and environmental sources (Fig. 4). There
were six occasions where TR34/L98H-containing isolates with matching MLGs were
found in both environmental and clinical sources and ﬁve occasions where TR46/Y121F/
T289A isolates were found in both sources.
There were 144 short tandem repeat of A. fumigatus (STRAf) genotype duplicates
found in both environmental and clinical locations. Of the 999 replicated simulations,
zero genotype duplicates were generated, showing that the chance that two STRAf
genotypes would randomly occur in both a clinical location and an environmental
location without a relationship is very low (P 0.01) (Fig. S10).
DISCUSSION
In recent years, the population genetic structure of Aspergillus fumigatus has been
well studied by utilizing a range of molecular markers to elucidate the genetic diversity
and life history of this ubiquitous human fungal pathogen (9, 26–29, 32, 33, 35).
Nevertheless, our understanding of the emergence of azole antifungal resistance and
the effect that this has had on the genetic diversity of contemporary A. fumigatus
FIG 3 Minimum-spanning networks showing the geographic distribution and genetic relationship of Aspergillus fumigatus multilocus genotypes (clones) with
either the TR34/L98H CYP51A allele or the TR46/Y121F/T289A CYP51A allele. The distance between MLGs is based on Bruvo’s genetic distances, which accounts
for the stepwise mutation of microsatellite loci. Each node represents an MLG with two or more individuals. Nodes that are more closely related have darker
and thicker edges, whereas nodes that are more distantly related have lighter and thinner edges.
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populations remains understudied. Here, we addressed these gaps in our knowledge by
exploiting the vast global STRAf collection held at the Centre of Expertise in Mycology,
Radboudumc/Canisius-Wilhelmina Ziekenhuis (CWZ), in Nijmegen, The Netherlands.
First, we show that the collection of 4,049 A. fumigatus strains can be clustered into two
broadly deﬁned populations and that two known resistance genotypes, TR34/L98H and
TR46/Y121F/T289A, are unevenly distributed across these two populations. Second,
resistant isolates harboring either TR34/L98H or TR46/Y121F/T289A are genetically
depauperate compared to the wild types. Third, resistant clones are globally distributed
and found in both environmental and clinical settings. Finally, we present AfumID, an
R Shiny application that allows users to easily explore the genetic relationship of novel
STRAf genotypes in relation to the full STRAf data set.
There has never been a deﬁnitive answer to the population differentiation of A.
fumigatus, with multiple studies reporting a range of optimal population subdivisions
(9, 26, 28, 29, 32). Here, we have shown that although there is no apparent clustering
with regard to raw Bruvo’s distances, when isolates are hierarchically clustered using
Ward’s method, which minimizes the total within-cluster variance and maximizes the
between-cluster variance, two broad clades are found. Differentiation of these two
clades was reinforced by a modiﬁed DAPC analysis, which revealed a detectable
FIG 4 Neighbor-joining dendrograms for azole-resistant Aspergillus fumigatus clones from clinical or environmental sources with either the TR34/L98H or the
TR46/Y121F/T289A allele. Each tip represents a resistant isolate that shares an MLG with two or more other isolates in the clone-corrected data set. Tip labels
are shaded by source of isolation. Bootstrap values were generated using 1,000 samples.
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difference in allele frequencies when populations were discriminated by prior hierar-
chical clustering. Studies exploiting multilocus sequence typing or genomic sequencing
have similarly revealed the presence of a biclade population structure (9, 29, 32, 35),
further substantiating our ﬁndings and advocating a robust deviation from panmixia.
Moreover, our demonstration of the nonrandom distribution of resistance genotypes
TR34/L98H and TR46/Y121F/T289A across the two populations suggests a genetic
component restricting the resistance genotype to one of the two populations. Sexual
crossing both within and between populations may provide more insight into the
potential for gene ﬂow across the metapopulation and the propensity for introgression
of resistant alleles (36, 37).
The genetic background of isolates harboring either TR34/L98H or TR46/Y121F/
T289A was less diverse than that of the nonresistant, wild-type isolates. All four indices
exhibited a signiﬁcant reduction in diversity, revealing a pattern consistent with the
rapid selection of beneﬁcial mutations and the clonal expansion of isolates with highly
ﬁt resistance genotypes (38). Recent genomic studies have observed an expansion of
the TR34/L98H genotype in India (32, 39), and according to our ﬁndings, it would appear
that this situation may be a common occurrence worldwide. Indeed, it is apparent that
identical clonal A. fumigatus isolates harboring TR34/L98H and TR46/Y121F/T289A occur
globally, evidence that large geographic distances are not a barrier to the potential
distribution of this species. This further supports the idea that A. fumigatus is a truly
global fungus with the potential to migrate across vast areas of land and sea by virtue
of both environmental (passive) and anthropogenic (active) dispersal (26). Numerous
country-based studies have now identiﬁed clinical and environmental azole-resistant
isolates harboring the two main resistance genotypes (40), and many have been
incorporated into the STRAf database used in this study. However, until now, under-
standing the relationship between these isolates was limited (26). Here, we distinctly
show that many azole-resistant isolates with identical microsatellite proﬁles occur
worldwide and present a globally important threat to the use and stewardship of this
important class of drugs (3).
Our study has also shown there to a be recurrent relationship between environ-
mental and clinical isolates. On multiple occasions, we have shown that azole-resistant
A. fumigatus clones sharing the exact same STRAf genotype were sourced from both
environmental and clinical locations, a pattern that we also show to be vanishingly
unlikely to occur by chance alone. This ﬁnding strengthens previous research that has
shown similar results (34, 41, 42). Moreover, considering our current understanding that
A. fumigatus conidia are unlikely to be transferred from patient to patient and are
therefore unlikely to transfer from patient to the environment, it is highly likely that
isolates harboring either TR34/L98H or TR46/Y121F/T289A have been acquired from
environmental sources (43).
Antifungal resistance is increasingly a global problem in both agricultural and health
care settings, and the evolution of azole resistance in A. fumigatus presents a worrisome
contribution to this precarious situation (2, 44). Understanding the manner by which
way azole resistance alleles are being distributed both genetically and spatially will
greatly enhance our knowledge of the evolution of resistance and may help to engineer
a response to the continued emergence of aspergillosis. By incorporating our analysis
into a user-friendly application, we have provided clinicians and researchers with a
method for the fast, automated characterization of A. fumigatus isolates that will inform
the epidemiological study of patients’ infections and inform drug stewardship decisions
in health care settings for this increasingly important pathogen.
MATERIALS AND METHODS
Study system. Short tandem repeat (STR) genotypes for the 4,049 isolates used in this study were
obtained from the short tandem repeat of A. fumigatus (STRAf) barcoding databank for clinical and
environmental A. fumigatus strains, which is based at the Centre of Expertise in Mycology, Radboudumc/
Canisius-Wilhelmina Ziekenhuis (CWZ), in Nijmegen, The Netherlands (45). The collection spans 26
countries across four continents (see Fig. S1 in the supplemental material) and includes metadata on
source environment (environmentally or clinically sourced) and the presence or absence of azole
Azole Resistance Distribution in Aspergillus fumigatus ®
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resistance genotypes TR34/L98H and TR46/Y121F/T289A, where available. All isolates in the database were
barcoded using a panel of nine short tandem repeat (STR) loci (namely, STRAf 2A, 2B, 2C, 3A, 3B, 3C, 4A,
4B, and 4C), as previously described (46) and validated (47). All STRAf genotypes were generated at CWZ.
Of the 4,049 isolates, a subset of 1,112 had been genotyped for either TR34/L98H, TR46/Y121F/T289A, or
wild-type (WT) CYP51A.
Global genetic structure of A. fumigatus. Due to the predominantly clonal reproductive strategy of
A. fumigatus, we used a multivariate, distance-based clustering approach, as opposed to methods that
rely on assumptions such as linkage equilibrium and panmixia, to investigate the presence of the
population structure (48, 49). First, considering that pockets of oversampled clones can complicate the
identiﬁcation of structure (50), a clone correction step was performed using the package poppr (v2.8.0)
(51) for R software (52). Clone correction was based on geographic origin, source environment, and
resistance genotype, in which a single isolate per multilocus genotype (MLG) was represented for each
of the three strata. A total of 2,784 isolates were retained following the clone correction step. Before
analysis, a genotype accumulation curve was generated to conﬁrm that the STRAf data set had the
correct number of loci (power) to discriminate between individuals in a population (Fig. S2) (50).
Genetic distances between individual isolates were determined using Bruvo’s distance in the R
package poppr, which utilizes a stepwise mutation model for microsatellite loci (53). Genetic distances
were calculated with 1,000-sample bootstrap support. Pairwise distances were hierarchically clustered
using Ward’s method with the R function hclust and visualized on an ultrametric dendrogram. Population
deﬁnitions (K) were selected using the R function cutree, where, on inspection, the tree was parsimo-
niously divided into two broad clusters (K 2). A principal-coordinate analysis (PCoA) (54) of genetic
distances between isolates was calculated using the R package ade4 (v1.7-11) (55), after ensuring that the
distances were Euclidean using the Cailliez transformation (ade4) (56, 57). The ﬁrst two principal axes of
PCoA were retained and visualized using a scatter plot where the two identiﬁed clusters were overlaid.
To identify whether populations deﬁned by Ward’s clustering were fundamentally different, a
modiﬁed discriminant analysis of principal components (DAPC) (58) in which the PCoA axes were used
as input variables was used. The resulting analysis identiﬁed linear combinations of the PCoA axes
exhibiting the strongest discrimination between clusters. DAPC was carried out using the package
adegenet (v2.1.1), using cross validation to select the optimal number of variables retained in the initial
dimension reduction step.
An interactive, web-based tool, AfumID, using information generated from this analysis was created
using the R package Shiny (v1.0.5) and can be accessed at http://afumid.shinyapps.io/afumID. AfumID
allows users to input microsatellite genotypes, together with metadata, to receive a brief characterization
of their isolate relative to a subset of the STRAf database (Fig. S3). AfumID outputs include a notiﬁcation
as to whether the STRAf proﬁle has been previously found and to which of the two populations the input
isolate belongs. Users can also browse the CWZ database and visualize their isolate’s position on the
PCoA scatter plot.
Genetic diversity of resistant A. fumigatus. The frequency of resistance genotypes across the
predicted populations (K 2) was calculated, and the signiﬁcance of the association was determined
using Pearson’s chi-square test in R. The association was visualized using an extended association plot
in the R package vcd (v1.4-4) (59). The association of a resistance allele to a speciﬁc population was
deemed signiﬁcant when P was 0.05.
A subset of 1,112 isolates with an annotated CYP51A allele (TR34/L98H, TR46/Y121F/T289A, or WT) was
retained to determine the genetic diversity of azole-resistant isolates, which was performed without
previously generated population associations. Allelic richness (total number of MLGs), the number of
effective multilocus genotypes (eMLGs), Simpson’s index (), the Shannon-Wiener diversity index (H), the
standardized Stoddart and Taylor’s index (G=), and the standardized index of association (rd) were all
calculated using the R package poppr. Rareﬁed MLG, given here as eMLG, is the number of MLGs for each
group at the lowest sample size across all groups. Simpson’s index is a measure of MLG diversity that
takes into account the number of different MLGs present, as well as the MLG abundance (60). Shannon-
Wiener diversity indices measures genotypic diversity by combining both MLG richness and MLG
evenness (61). The standardized Stoddart and Taylor’s index measures genotypic diversity while taking
into account sample sizes (62, 63). The standardized index of association has been widely used as a tool
to detect clonal reproduction within populations (64–66) and is used here to measure the relatedness of
resistant and wild-type A. fumigatus isolates. All indices were calculated with (n 750) and without
(n 1112) a clone correction step, to determine the importance of clones and identify patterns of clonal
expansion. Conﬁdence intervals were generated using 1,000 bootstrap samples. An analysis of variance
was used to compare the diversity indices of different resistance genotypes, and Tukey’s test was used
to identify which genotypes differed signiﬁcantly.
Distribution of multidrug-resistant clones. To examine the global distribution of drug-resistant
clones, a subset of resistant isolates with identical MLGs and with at least two or more representative
individuals was used to generate minimum-spanning networks (MSN) based on Bruvo’s distances, using
the R package poppr. Each node of the MSN represents a single MLG that consists of two or more
individuals. Nodes or MLGs that are more closely related have darker and thicker edges, whereas nodes
that are more distantly related have lighter and thinner edges.
To test for spatial patterns of genetic variation via isolation by distance (IBD), a Mantel test was
performed to elucidate an association between geographic distance and the genetic divergence of
azole-resistant isolates (67). Pairwise geographic distances between countries were based on the
great-circle distance according to the haversine formula, which was computed using the R package
geosphere (v1.5-7) (68). A pairwise ﬁxation index (FST) between countries was calculated using the R
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package hierfstat (v0.04-22) (69) for the TR34/L98H, TR46/Y121F/T289A, and WT genotypes. A Mantel test
was performed on the matrices of the represented pairwise FST and geographic distances using the R
package ade4 and 999 permutations.
A nonparametric bootstrapped (1,000-sample) unweighted pair group method using average link-
ages (UPGMA) dendrogram was produced using Bruvo’s distances to highlight the relatedness of a
subset of resistant isolates with identical MLGs sourced from clinical and environmental locales. We used
a nonparametric, Monte Carlo test to assess whether the occurrence of isolates with identical MLGs in
both environmental and clinical settings deviated signiﬁcantly from random expectations. The number
of observed genotype duplicates across both settings was used as a test statistic. To generate the
expected distribution of the statistic, we simulated environmental and clinical genotypes from the
groups’ allele frequencies using the function hybridize in the adegenet package. A total of 999
independent random replicates were used for the test. The P value was calculated as the proportion of
simulations greater than or equal to the original test statistic.
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